In the SLE context, IFNs prime mature neutrophils in vivo, triggering NET release that activates pDCs through DNA- and TLR9-dependent mechanisms, resulting in enhanced IFN-α production (Garcia-Romo et al., 2011). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.